What does high VLDL cholesterol mean?

High VLDL cholesterol indicates elevated triglycerides and increased cardiovascular risk, as VLDL particles transport fats through your bloodstream. Levels above 30 mg/dL require attention through diet changes, exercise, and potentially medication.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding VLDL Cholesterol

Very low-density lipoprotein (VLDL) cholesterol is one of the five major types of lipoproteins that transport fats and cholesterol through your bloodstream. While you might be familiar with LDL (bad cholesterol) and HDL (good cholesterol), VLDL plays a crucial but often overlooked role in your cardiovascular health.

Your liver produces VLDL particles to carry triglycerides, a type of fat, to tissues throughout your body. As VLDL particles release their triglyceride cargo, they gradually transform into LDL cholesterol. This makes VLDL a precursor to LDL, and understanding your VLDL levels provides valuable insight into your overall lipid profile and heart disease risk.

The Role of VLDL in Your Body

VLDL particles serve as the body's primary transport system for endogenously produced triglycerides. After you eat, your liver converts excess calories, particularly from carbohydrates and fats, into triglycerides. These triglycerides are then packaged into VLDL particles along with cholesterol, proteins, and phospholipids for distribution to cells that need energy or fat storage.

VLDL and Triglyceride Level Categories

VLDL Level (mg/dL)Triglyceride Level (mg/dL)Risk CategoryRecommended Action
Below 30<30<150NormalMaintain healthy lifestyle
30-4030-40150-199Borderline HighLifestyle modifications recommended
Above 40>40200-499HighAggressive lifestyle changes, consider medication
Above 80>80>500Very HighImmediate medical attention, medication likely needed

VLDL is calculated as triglycerides divided by 5 when triglycerides are below 400 mg/dL.

While this process is essential for normal metabolism, problems arise when your body produces too much VLDL. Excess VLDL particles contribute to the buildup of plaque in your arteries, a condition called atherosclerosis, which significantly increases your risk of heart attack and stroke.

What Are Normal and High VLDL Levels?

VLDL cholesterol levels are typically estimated rather than directly measured in standard lipid panels. Labs calculate VLDL by dividing your triglyceride level by 5 (when triglycerides are below 400 mg/dL). This estimation works because VLDL particles carry approximately 60-70% of the triglycerides in your blood. Understanding these levels helps you assess your cardiovascular risk more accurately.

According to medical guidelines, normal VLDL cholesterol levels should be below 30 mg/dL (0.78 mmol/L). Levels above this threshold are considered high and warrant attention. Since VLDL is calculated from triglycerides, high VLDL typically indicates elevated triglyceride levels, which should ideally be below 150 mg/dL.

How VLDL Relates to Other Cholesterol Numbers

Your VLDL level is interconnected with other lipid measurements. High VLDL often coincides with high triglycerides, low HDL cholesterol, and sometimes elevated LDL cholesterol. This combination, often called atherogenic dyslipidemia, is particularly dangerous for cardiovascular health and is commonly seen in people with metabolic syndrome or type 2 diabetes.

Causes of High VLDL Cholesterol

Multiple factors can contribute to elevated VLDL cholesterol levels. Understanding these causes helps you identify which aspects of your health might need attention and guides your approach to lowering VLDL.

Dietary and Lifestyle Factors

  • Excessive consumption of refined carbohydrates and added sugars
  • High intake of saturated and trans fats
  • Regular alcohol consumption
  • Sedentary lifestyle with minimal physical activity
  • Being overweight or obese, particularly with excess abdominal fat
  • Smoking, which affects lipid metabolism

Medical Conditions

Several health conditions can cause or contribute to high VLDL levels:

  • Type 2 diabetes and insulin resistance
  • Metabolic syndrome
  • Hypothyroidism (underactive thyroid)
  • Kidney disease
  • Liver disease
  • Polycystic ovary syndrome (PCOS)
  • Cushing's syndrome

Medications and Other Factors

Certain medications can raise VLDL levels as a side effect, including corticosteroids, beta-blockers, thiazide diuretics, and some HIV medications. Additionally, genetic factors play a role, with conditions like familial hypertriglyceridemia causing inherited high VLDL and triglyceride levels.

Health Risks Associated with High VLDL

Elevated VLDL cholesterol poses significant health risks, primarily related to cardiovascular disease. When VLDL levels remain high over time, they contribute to the development of atherosclerosis, where plaque builds up inside your arteries, narrowing them and restricting blood flow.

The cardiovascular risks associated with high VLDL include:

  • Coronary artery disease, leading to angina and heart attacks
  • Cerebrovascular disease, increasing stroke risk
  • Peripheral artery disease, causing leg pain and circulation problems
  • Increased risk of blood clots
  • Higher likelihood of developing metabolic syndrome

Beyond cardiovascular concerns, high VLDL levels often indicate broader metabolic dysfunction. People with elevated VLDL frequently have insulin resistance, which can progress to type 2 diabetes. The combination of high VLDL, high triglycerides, and insulin resistance creates a particularly harmful metabolic environment that accelerates aging and increases inflammation throughout the body.

Symptoms and Detection

High VLDL cholesterol typically doesn't cause noticeable symptoms on its own, which is why it's often called a silent risk factor. Most people discover they have high VLDL only through blood testing. However, extremely high triglyceride levels (which correlate with very high VLDL) can sometimes cause:

  • Xanthomas (fatty deposits under the skin)
  • Xanthelasmas (yellowish deposits around the eyelids)
  • Corneal arcus (gray-white ring around the cornea)
  • Abdominal pain from pancreatitis (in severe cases)

Since high VLDL rarely presents symptoms until significant damage has occurred, regular testing is crucial for early detection and prevention. A comprehensive lipid panel that includes triglyceride measurement allows for VLDL calculation and provides a complete picture of your cardiovascular risk.

How to Lower High VLDL Cholesterol

Reducing VLDL cholesterol requires a comprehensive approach that addresses the underlying causes. Since VLDL is closely tied to triglyceride levels, strategies that lower triglycerides will also reduce VLDL.

Dietary Changes

Diet plays a crucial role in managing VLDL levels. Focus on these dietary modifications:

  • Reduce refined carbohydrates and added sugars significantly
  • Choose complex carbohydrates with high fiber content
  • Increase omega-3 fatty acids from fish, walnuts, and flaxseeds
  • Replace saturated fats with monounsaturated fats from olive oil and avocados
  • Eliminate trans fats completely
  • Limit alcohol consumption or avoid it entirely
  • Increase soluble fiber intake from oats, beans, and vegetables

Exercise and Weight Management

Regular physical activity is one of the most effective ways to lower VLDL cholesterol. Aim for at least 150 minutes of moderate-intensity aerobic exercise weekly, plus two days of strength training. Exercise helps by improving insulin sensitivity, promoting weight loss, and directly affecting lipid metabolism.

Weight loss, particularly reducing abdominal fat, significantly impacts VLDL levels. Even a modest 5-10% reduction in body weight can lead to substantial improvements in your lipid profile.

Medications When Necessary

When lifestyle changes aren't sufficient, medications may be necessary. Common options include:

  • Statins, which primarily lower LDL but also reduce VLDL
  • Fibrates, particularly effective for lowering triglycerides and VLDL
  • Omega-3 fatty acid supplements (prescription strength)
  • Niacin, though less commonly used due to side effects
  • PCSK9 inhibitors for severe cases

Monitoring Your Progress

Regular monitoring is essential when working to lower VLDL cholesterol. Initial testing should include a complete lipid panel, and follow-up testing every 3-6 months helps track your progress and adjust your treatment plan as needed.

Beyond VLDL and triglycerides, monitoring should include other cardiovascular risk markers like apolipoprotein B (ApoB), which provides a more accurate count of atherogenic particles than traditional cholesterol measurements. Additionally, tracking inflammatory markers like high-sensitivity C-reactive protein (hs-CRP) offers insight into your overall cardiovascular risk.

Taking Action for Better Heart Health

High VLDL cholesterol is a significant but modifiable risk factor for cardiovascular disease. While it rarely causes symptoms, its impact on your long-term health can be profound. The good news is that VLDL levels respond well to lifestyle interventions, and most people can achieve significant improvements through diet, exercise, and weight management.

Understanding your VLDL level as part of your complete lipid profile empowers you to take targeted action for better heart health. Whether through lifestyle changes alone or in combination with medication, lowering high VLDL cholesterol is an achievable goal that significantly reduces your risk of heart disease and improves your overall metabolic health.

Remember that managing VLDL is not just about hitting a target number but about creating sustainable habits that support your cardiovascular system for years to come. Regular testing, consistent lifestyle modifications, and working with healthcare providers when needed form the foundation of effective VLDL management and optimal heart health.

References

  1. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626-635.[Link][DOI]
  2. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.[Link][PubMed]
  3. Packard CJ, Boren J, Taskinen MR. Causes and Consequences of Hypertriglyceridemia. Front Endocrinol (Lausanne). 2020;11:252.[Link][PubMed][DOI]
  4. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989.[PubMed][DOI]
  5. Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies. Eur Heart J. 2021;42(47):4791-4806.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL cholesterol at home?

You can test your VLDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive lipid testing with VLDL calculation, along with other crucial cardiovascular markers like ApoB and hs-CRP.

What's the difference between VLDL and LDL cholesterol?

VLDL particles are larger and carry mostly triglycerides from your liver to tissues, while LDL particles are smaller and carry mostly cholesterol. VLDL transforms into LDL after delivering its triglyceride cargo, making VLDL a precursor to LDL cholesterol.

Can I have high VLDL with normal LDL levels?

Yes, it's possible to have elevated VLDL with normal LDL levels, especially if you have high triglycerides. This pattern is common in metabolic syndrome and insulin resistance, where triglyceride metabolism is impaired while LDL production remains relatively normal.

How quickly can I lower my VLDL cholesterol?

VLDL levels can respond relatively quickly to lifestyle changes. With significant dietary modifications and regular exercise, you may see improvements in 4-6 weeks. However, achieving and maintaining optimal levels typically requires 3-6 months of consistent healthy habits.

Are there foods that specifically lower VLDL?

Yes, foods rich in omega-3 fatty acids (fatty fish, walnuts, flaxseeds), soluble fiber (oats, beans, apples), and monounsaturated fats (olive oil, avocados) can help lower VLDL. Avoiding refined sugars and processed carbohydrates is equally important for VLDL reduction.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details